For the international investments, they are mostly under business improvement which attributed to negative performances in 2014 as stated below:
• In Malaysia, our business was affected by high competition arising from new capacity added up and higher crude palm kernel oil prices in South-East Asia region.
• In France, our business faced a weak demand in Europe which led to the decrease in overall sales. It also recorded provision for business restructuring and impairment of assets due to business strategy realignment in order to improve high-performance production units.
• In the USA, our business mainly conducts the research and development in bio-based chemicals which were generally incurred expense.